Submission Details
| 510(k) Number | K221899 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 30, 2022 |
| Decision Date | January 20, 2023 |
| Days to Decision | 204 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
K221899 is an FDA 510(k) clearance for the The Sensititre YeastOne Susceptibility System with Caspofungin in the dilution range of 0.015-16ug/ml, a Susceptibility Test Plate, Antifungal (Class II — Special Controls, product code NGZ), submitted by Thermo Fisher Scientific (Oakwood Village, US). The FDA issued a Cleared decision on January 20, 2023, 204 days after receiving the submission on June 30, 2022. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.1640.
| 510(k) Number | K221899 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 30, 2022 |
| Decision Date | January 20, 2023 |
| Days to Decision | 204 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
| Product Code | NGZ — Susceptibility Test Plate, Antifungal |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.1640 |
| Definition | The Device Is An In Vitro Diagnostic Device Intended For Use In Determining Quantitative Susceptibility Of Candida Species To Various Antifungal Agents Diluted In Varying Concentration In A Microtiter Plate Format. |